Literature DB >> 17172593

Heredity and DNA methylation in colorectal cancer.

J R Jass.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17172593      PMCID： PMC1856650     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  15 in total

1.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.

Authors:  Daniel J Weisenberger; Kimberly D Siegmund; Mihaela Campan; Joanne Young; Tiffany I Long; Mark A Faasse; Gyeong Hoon Kang; Martin Widschwendter; Deborah Weener; Daniel Buchanan; Hoey Koh; Lisa Simms; Melissa Barker; Barbara Leggett; Joan Levine; Myungjin Kim; Amy J French; Stephen N Thibodeau; Jeremy Jass; Robert Haile; Peter W Laird
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

2.  Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer.

Authors:  Joanne Young; Melissa A Barker; Lisa A Simms; Michael D Walsh; Kelli G Biden; Daniel Buchanan; Ron Buttenshaw; Vicki L J Whitehall; Sven Arnold; Leigh Jackson; Takeshi Kambara; Kevin J Spring; Mark A Jenkins; Graeme J Walker; John L Hopper; Barbara A Leggett; Jeremy R Jass
Journal:  Clin Gastroenterol Hepatol       Date:  2005-03       Impact factor: 11.382

3.  Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis.

Authors:  J R Jass; D S Cottier; V Pokos; S Parry; I M Winship
Journal:  Pathology       Date:  1997-02       Impact factor: 5.306

4.  The CpG island methylator phenotype is not associated with a personal or family history of cancer.

Authors:  Robyn Lynne Ward; Rachel Williams; Matthew Law; Nicholas John Hawkins
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

5.  A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor.

Authors:  Isabella Gazzoli; Massimo Loda; Judy Garber; Sapna Syngal; Richard D Kolodner
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

6.  Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.

Authors:  Marsha L Frazier; Lixuan Xi; Jihong Zong; Nancy Viscofsky; Asif Rashid; Elsie F Wu; Patrick M Lynch; Christopher I Amos; Jean-Pierre J Issa
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

7.  Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability.

Authors:  Yasuyuki Miyakura; Kokichi Sugano; Takayuki Akasu; Teruhiko Yoshida; Masato Maekawa; Soh Saitoh; Hideyuki Sasaki; Tadashi Nomizu; Fumio Konishi; Shin Fujita; Yoshihiro Moriya; Hideo Nagai
Journal:  Clin Gastroenterol Hepatol       Date:  2004-02       Impact factor: 11.382

8.  Germline epimutation of MLH1 in individuals with multiple cancers.

Authors:  Catherine M Suter; David I K Martin; Robyn L Ward
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

9.  Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.

Authors:  Hengmi Cui; Marcia Cruz-Correa; Francis M Giardiello; David F Hutcheon; David R Kafonek; Sheri Brandenburg; Yiqian Wu; Xiaobing He; Neil R Powe; Andrew P Feinberg
Journal:  Science       Date:  2003-03-14       Impact factor: 47.728

10.  Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.

Authors:  H Nakagawa; R B Chadwick; P Peltomaki; C Plass; Y Nakamura; A de La Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205
View more
  6 in total

Review 1.  Epigenetic programming of the germ line: effects of endocrine disruptors on the development of transgenerational disease.

Authors:  Matthew D Anway; Michael K Skinner
Journal:  Reprod Biomed Online       Date:  2008-01       Impact factor: 3.828

2.  Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome.

Authors:  Changyu Zhou; Jiayu Li; Jiarui Li; Yingchun Wan; Tao Li; Piyong Ma; Yingjian Wang; Haiyan Sang
Journal:  Oncol Lett       Date:  2016-07-06       Impact factor: 2.967

3.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

4.  Genomic instability and carcinogenesis: an update.

Authors:  Wael M Abdel-Rahman
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

Review 5.  Epigenetic transgenerational actions of vinclozolin on the development of disease and cancer.

Authors:  Michael K Skinner; Matthew D Anway
Journal:  Crit Rev Oncog       Date:  2007-08

Review 6.  Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer.

Authors:  Jung-Jin Park; Minyoung Lee
Journal:  Gut Liver       Date:  2013-11-11       Impact factor: 4.519
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.